NVS - Novartis Revenue Jumps And Other News: The Good Bad And Ugly Of Biopharma
Novartis Revenue Jumps but Net Income Falls for Q4
Novartis (NVS) posted mixed numbers for its fourth quarter. The company announced strong revenue growth but showed negative impact of higher taxes. Its core operating income for the quarter stood at $3.46 billion, up 11 percent while its net income showed decline of 7 percent to $1.1 billion. The decline was mainly due to one-time tax charge. Novartis reported its revenue from continuing operations at $12.4 billion, up 8 percent.
Novartis reported that its revenue was mainly helped by the continued strong performance shown